Neurostimulation and Motor Training for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help people with spinal cord injuries improve motor skills, such as hand movements. It combines paired neurostimulation with specialized motor training to determine if it enhances limb use. The trial includes three groups: one receives the actual treatment (PCMS + Contralateral Motor Training), another receives a placebo version (Sham PCMS + Contralateral Motor Training), and the last group rests (PCMS + Rest). Individuals with a neck-level spinal cord injury who retain some muscle movement might be suitable for this trial. As an Early Phase 1 trial, this research aims to understand how the treatment works in people, offering participants the opportunity to be among the first to experience this innovative approach.
Will I have to stop taking my current medications?
The trial excludes people who are currently using medications that can lower the seizure threshold, like bupropion or amphetamines. If you are taking these medications, you would need to stop them to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have shown that techniques like PCMS (paired corticospinal-motoneuronal stimulation) improve movement abilities after a spinal cord injury. For example, research indicates that PCMS helps individuals with spinal cord injuries gain better muscle control and improve hand movements. Importantly, these studies report that the treatment is generally well-tolerated, with no major side effects noted.
When combined with rest, further studies found that PCMS can alter brain and spinal cord communication, potentially aiding movement recovery. These findings suggest that the treatment is safe and could be a promising method to help individuals with spinal cord injuries regain movement. Overall, the evidence supports the safety of these treatments, though ongoing research will provide more detailed insights.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the PCMS + Contralateral Motor Training treatment because it offers a novel approach to spinal cord injury rehabilitation by combining neurostimulation with targeted motor exercises. Unlike traditional treatments that often focus solely on physical therapy or medication, this treatment uses paired corticospinal-motor stimulation (PCMS) to potentially enhance neural plasticity and recovery. The integration of contralateral motor training aims to promote motor function in affected limbs by leveraging the brain's ability to reorganize and strengthen new pathways. This innovative combination could lead to improved outcomes in motor recovery compared to current standard care options.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that paired corticospinal-motoneuronal stimulation (PCMS), combined with exercises for the opposite side of the body, can improve movement skills after a spinal cord injury (SCI). In this trial, participants may receive PCMS with contralateral motor training, which studies indicate strengthens brain-to-muscle signals, enhancing movement control. Alternatively, some participants will receive PCMS with rest, or a sham version of the treatment combined with contralateral motor training. One study found that using PCMS with practice helped individuals retain improved skills for at least a week. Overall, PCMS has demonstrated promising results in enhancing movement ability and muscle strength in individuals with SCI.12678
Who Is on the Research Team?
Ela Plow, PhD
Principal Investigator
The Cleveland Clinic
Are You a Good Fit for This Trial?
This trial is for individuals with cervical Spinal Cord Injury (SCI) who are interested in improving their motor and hand dexterity skills. Specific eligibility criteria details were not provided, so participants should inquire about inclusion and exclusion requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessments including CUE-T, COPM, GRASSP, SCIM, and LTPAQ-SCI are conducted to evaluate participants' initial functional abilities and participation restrictions.
Treatment
Participants undergo paired corticospinal-motor neuronal stimulation (PCMS) combined with contralateral motor training or rest, with assessments of spinal and cortical excitability, ballistic acceleration, and finger dexterity.
Follow-up
Participants are monitored for changes in motor function and dexterity post-treatment, including assessments of spinal and cortical excitability and finger dexterity.
What Are the Treatments Tested in This Trial?
Interventions
- PCMS + Contralateral Motor Training
- PCMS + Rest
- Sham PCMS + Contralateral Motor Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
The Craig H. Neilsen Foundation
Collaborator